疑似急性心肌梗死患者补充氧疗随机试验荟萃分析
该荟萃分析纳入8项随机对照试验共7998例疑似或确诊急性心肌梗死患者,比较补充氧疗与室内空气。氧疗未降低院内死亡(OR 1.11,95%CI 0.69-1.77)或30天死亡(OR 1.09,95%CI 0.80-1.50),确诊AMI亚组结果相似;氧疗降低低氧血症风险(OR 0.29,95%CI 0.17-0.47)。结论支持对血氧正常患者不再常规给氧。
要点
- 氧疗未降低疑似AMI患者院内死亡和30天死亡风险。
- 确诊AMI亚组中氧疗对死亡率无获益。
- 氧疗显著降低低氧血症风险,但无其他临床获益。
核心结论
- 补充氧疗虽常用,但未与重要临床获益相关,8项随机试验结果支持对血氧正常患者放弃常规给氧。
研究设计与样本
- 聚合数据荟萃分析,检索多个数据库至2017年9月30日,纳入8项随机对照试验共7998例参与者(氧疗组3982例,空气组4002例)。
主要发现
- 氧疗未降低疑似AMI患者院内死亡风险(OR 1.11,95%CI 0.69-1.77)或30天死亡风险(OR 1.09,95%CI 0.80-1.50)。
- 确诊AMI亚组中结果与总体相似。
- 亚组患者基于心脏MRI的心肌梗死面积在氧疗组与无氧疗组间无差异。
- 氧疗降低低氧血症风险(OR 0.29,95%CI 0.17-0.47)。
临床怎么用
- 对血氧正常的疑似或确诊AMI患者,不应常规给予补充氧疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although oxygen therapy has been used for over a century in the management of patients with suspected acute myocardial infarction (AMI), recent studies have raised concerns around the efficacy and safety of supplemental oxygen in normoxaemic patients. OBJECTIVE: To synthesise the evidence from randomised controlled trials (RCTs) that investigated the effects of supplemental oxygen therapy compared with room air in patients with suspected or confirmed AMI. METHODS: For this aggregate data meta-analysis, multiple databases were searched from inception to 30 September 2017. RCTs with any length of follow-up and any outcome measure were included if they studied the use of supplemental O2 therapy administered by any device at normal pressure compared with room air. Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, an investigator assessed all the included studies and extracted the data. Outcomes of interests included mortality, troponin levels, infarct size, pain and hypoxaemia. RESULTS: Eight RCTs with a total of 7998 participants (3982 and 4002 patients in O2 and air groups, respectively) were identified and pooled. In-hospital and 30-day death occurred in 135 and 149 patients, respectively. Oxygen therapy did not reduce the risk of in-hospital (OR, 1.11 (95% CI 0.69 to 1.77)) or 30-day mortality (OR, 1.09 (95% CI 0.80 to 1.50)) in patients with suspected AMI, and the results remained similar in the subgroup of patients with confirmed AMI. The infarct size (based on cardiac MRI) in a subgroup of patients was not different between groups with and without O2 therapy. O2 therapy reduced the risk of hypoxaemia (OR, 0.29 (95% CI 0.17 to 0.47)). CONCLUSION: Although supplemental O2 therapy is commonly used, it was not associated with important clinical benefits. These findings from eight RCTs support departing from the usual practice of administering oxygen in normoxaemic patients.
引用
- Sepehrvand N, James SK, Stub D, et al. Effects of supplemental oxygen therapy in patients with suspected acute myocardial infarction: a meta-analysis of randomised clinical trials. Heart. 2018. PMID: 29599378. doi:10.1136/heartjnl-2018-313089
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。